Mitochondria-derived vesicles: A promising and potential target for tumour therapy

Abstract

Mitochondria-derived vesicles (MDVs) participate in early cellular defence mechanisms initiated in response to mitochondrial damage. They maintain mitochondrial quality control (MQC) by clearing damaged mitochondrial components, thereby ensuring the normal functioning of cellular processes. This process is crucial for cell survival and health, as mitochondria are the energy factories of cells, and their damage can cause cellular dysfunction and even death. Recent studies have shown that MDVs not only maintain mitochondrial health but also have a significant impact on tumour progression. MDVs selectively encapsulate and transport damaged mitochondrial proteins under oxidative stress and reduce the adverse effects of mitochondrial damage on cells, which may promote the survival and proliferation of tumour cells. Furthermore, it has been indicated that after cells experience mild stress, the number of MDVs significantly increases within 2–6 h, whereas mitophagy, a process of clearing damaged mitochondria, occurs 12–24 h later. This suggests that MDVs play a critical role in the early stress response of cells. Moreover, MDVs also have a significant role in intercellular communication, specifically in the tumour microenvironment. They can carry and transmit various bioactive molecules, such as proteins, nucleic acids, and lipids, which regulate tumour cell's growth, invasion, and metastasis. This intercellular communication may facilitate tumour spread and metastasis, making MDVs a potential therapeutic target. Advances in MDV research have identified novel biomarkers, clarified regulatory mechanisms, and provided evidence for clinical use. These breakthroughs pave the way for novel MDV-targeted therapies, offering improved treatment alternatives for cancer patients. Further research can identify MDVs' role in tumour development and elucidate future cancer treatment horizons.

Keywords

mitochondria-derived vesicle / target / transport pathway / tumour progression / tumour therapy

References

[1] Jasra IT, Cuesta-Gomez N, Verhoeff K, Marfil-Garza BA, Dadheech N, Shapiro AMJ. Mitochondrial regulation in human pluripotent stem cells during reprogramming and beta cell differentiation. Front Endocrinol (Lausanne). 2023; 14: 1236472.

[2] Rongvaux A. Innate immunity and tolerance toward mitochondria. Mitochondrion. 2018; 41: 14-20.

[3] Zhang SS, Zhou S, Crowley-McHattan ZJ, Wang RY, Li JP. A review of the role of endo/sarcoplasmic reticulum-mitochondria Ca(2+) transport in diseases and skeletal muscle function. Int J Environ Res Public Health. 2021; 18.

[4] Amador-Martínez I, Aparicio-Trejo OE, Bernabe-Yepes B, et al. Mitochondrial impairment: a link for inflammatory responses activation in the cardiorenal syndrome Type 4. Int J Mol Sci. 2023; 24.

[5] Barabino S, Lombardi S, Zilocchi M. Keep in touch: a perspective on the mitochondrial social network and its implication in health and disease. Cell Death Discov. 2023; 9: 417.

[6] Campello S, Strappazzon F, Cecconi F. Mitochondrial dismissal in mammals, from protein degradation to mitophagy. Biochim Biophys Acta. 2014; 1837: 451-460.

[7] Mukkala AN, Jerkic M, Khan Z, Szaszi K, Kapus A, Rotstein O. Therapeutic effects of mesenchymal stromal cells require mitochondrial transfer and quality control. Int J Mol Sci. 2023; 24.

[8] Li Y, Fan J, Zhu W, Niu Y, Zhang A. Therapeutic potential targeting podocyte mitochondrial dysfunction in focal segmental glomerulosclerosis. Kidney Dis (Basel). 2023; 9: 254-264.

[9] Zhou Y, Suo W, Zhang X, et al. Targeting mitochondrial quality control for diabetic cardiomyopathy: therapeutic potential of hypoglycemic drugs. Biomed Pharmacother. 2023; 168: 115669.

[10] Ma J, Liu L, Song L, et al. Integration of FUNDC1-associated mitochondrial protein import and mitochondrial quality control contributes to TDP-43 degradation. Cell Death Dis. 2023; 14: 735.

[11] Liu Y, Fu T, Li G, et al. Mitochondrial transfer between cell crosstalk - an emerging role in mitochondrial quality control. Age Res Rev. 2023; 91: 102038.

[12] Gorbunova AS, Zamaraev AV, Yapryntseva MA, et al. Prognostic signature based on mitochondria quality control proteins for the prediction of lung adenocarcinoma patients survival. Cell Death Discov. 2023; 9: 352.

[13] Soubannier V, McLelland G, Zunino R, et al. A vesicular transport pathway shuttles cargo from mitochondria to lysosomes. Curr Biol. 2012; 22: 135-141.

[14] An X, Ma X, Liu H, et al. Inhibition of PDGFRbeta alleviates endothelial cell apoptotic injury caused by DRP-1 overexpression and mitochondria fusion failure after mitophagy. Cell Death Dis. 2023; 14: 756.

[15] Noone J, Rochfort KD, O'Sullivan F, O'Gorman DJ. SIRT4 is a regulator of human skeletal muscle fatty acid metabolism influencing inner and outer mitochondrial membrane-mediated fusion. Cell Signal. 2023; 112: 110931.

[16] Lee H, Smith SB, Sheu SS, Yoon Y. The short variant of optic atrophy 1 (OPA1) improves cell survival under oxidative stress. J Biol Chem. 2020; 295: 6543-6560.

[17] Chen L, Qin Y, Liu B, et al. PGC-1alpha-mediated mitochondrial quality control: molecular mechanisms and implications for heart failure. Front Cell Dev Biol. 2022; 10: 871357.

[18] Yoshii SR, Mizushima N. Autophagy machinery in the context of mammalian mitophagy. Biochim Biophys Acta. 2015; 1853: 2797-2801.

[19] Bozi LH, Bechara LR, Dos Santos AF, Campos JC. Mitochondrial-derived vesicles: a new player in cardiac mitochondrial quality control. J Physiol. 2016; 594: 6077-6078.

[20] Borcherding N, Brestoff JR. The power and potential of mitochondria transfer. Nature. 2023; 623: 283-291.

[21] Saha T, Dash C, Jayabalan R, et al. Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells. Nat Nanotechnol. 2022; 17: 98-106.

[22] Li S, Sheng ZH. Energy matters: presynaptic metabolism and the maintenance of synaptic transmission. Nat Rev Neurosci. 2022; 23: 4-22.

[23] Kubat GB, Bouhamida E, Ulger O, et al. Mitochondrial dysfunction and skeletal muscle atrophy: causes, mechanisms, and treatment strategies. Mitochondrion. 2023; 72: 33-58.

[24] Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024; 74: 12-49.

[25] Ma S, Zhang J, Yan T, et al. Novel strategies to reverse chemoresistance in colorectal cancer. Cancer Med. 2023; 12: 11073-11096.

[26] Zhou R, Tang X, Wang Y. Emerging strategies to investigate the biology of early cancer. Nat Rev Cancer. 2024; 24: 850-866.

[27] Liu Z, Chen J, Ren Y, et al. Multi-stage mechanisms of tumor metastasis and therapeutic strategies. Signal Transduct Targeted Ther. 2024; 9: 270.

[28] Esposito M, Ganesan S, Kang Y. Emerging strategies for treating metastasis. Nat Cancer. 2021; 2: 258-270.

[29] Jokhadze N, Das A, Dizon DS. Global cancer statistics: a healthy population relies on population health. CA Cancer J Clin. 2024; 74: 224-226.

[30] Watson DC, Bayik D, Storevik S, et al. GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity. Nat Cancer. 2023; 4: 648-664.

[31] Sugiura A, McLelland GL, Fon EA, McBride HM. A new pathway for mitochondrial quality control: mitochondrial-derived vesicles. EMBO J. 2014; 33: 2142-2156.

[32] Towers CG, Wodetzki DK, Thorburn J, Smith KR, Caino MC, Thorburn A. Mitochondrial-derived vesicles compensate for loss of LC3-mediated mitophagy. Dev Cell. 2021; 56: 2029-2042e2025.

[33] Gagliardi S, Mitruccio M, Di Corato R, et al. Defects of mitochondria-lysosomes communication induce secretion of mitochondria-derived vesicles and drive chemoresistance in ovarian cancer cells. Cell Commun Signal. 2024; 22: 165.

[34] Zecchini V, Paupe V, Herranz-Montoya I, et al. Fumarate induces vesicular release of mtDNA to drive innate immunity. Nature. 2023; 615: 499-506.

[35] Rabas N, Palmer S, Mitchell L, et al. PINK1 drives production of mtDNA-containing extracellular vesicles to promote invasiveness. J Cell Biol. 2021; 220.

[36] Neuspiel M, Schauss AC, Braschi E, et al. Cargo-selected transport from the mitochondria to peroxisomes is mediated by vesicular carriers. Curr Biol. 2008; 18: 102-108.

[37] Yamashita A, Fujimoto M, Katayama K, Yamaoka S, Tsutsumi N, Arimura S. Formation of mitochondrial outer membrane derived protrusions and vesicles in Arabidopsis thaliana. PLoS One. 2016; 11: e0146717.

[38] Ramirez A, Old W, Selwood DL, Liu X. Cannabidiol activates PINK1-Parkin-dependent mitophagy and mitochondrial-derived vesicles. Eur J Cell Biol. 2022; 101: 151185.

[39] Schubert AF, Gladkova C, Pardon E, et al. Structure of PINK1 in complex with its substrate ubiquitin. Nature. 2017; 552: 51-56.

[40] McLelland GL, Soubannier V, Chen CX, McBride HM, Fon EA. Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochondrial quality control. EMBO J. 2014; 33: 282-295.

[41] Matheoud D, Sugiura A, Bellemare-Pelletier A, et al. Parkinson's disease-related proteins PINK1 and Parkin repress mitochondrial antigen presentation. Cell. 2016; 166: 314-327.

[42] Popov LD. Mitochondrial-derived vesicles: recent insights. J Cell Mol Med. 2022; 26: 3323-3328.

[43] Schöneberg J, Lehmann M, Ullrich A, et al. Lipid-mediated PX-BAR domain recruitment couples local membrane constriction to endocytic vesicle fission. Nat Commun. 2017; 8: 15873.

[44] König T, McBride HM. Mitochondrial-derived vesicles in metabolism, disease, and aging. Cell Metab. 2024; 36: 21-35.

[45] König T, Nolte H, Aaltonen MJ, et al. MIROs and DRP1 drive mitochondrial-derived vesicle biogenesis and promote quality control. Nat Cell Biol. 2021; 23: 1271-1286.

[46] Picca A, Guerra F, Calvani R, et al. Generation and release of mitochondrial-derived vesicles in health, aging and disease. J Clin Med. 2020; 9.

[47] Chaudhary PK, Kim S, Kim S. Shedding light on the cell biology of platelet-derived extracellular vesicles and their biomedical applications. Life (Basel). 2023; 13.

[48] Pegtel DM, Gould SJ. Exosomes. Annu Rev Biochem. 2019; 88: 487-514.

[49] Yang S, Zheng B, Raza F, et al. Tumor-derived microvesicles for cancer therapy. Biomater Sci. 2024; 12: 1131-1150.

[50] Gao P, Zhou L, Wu J, et al. Riding apoptotic bodies for cell-cell transmission by African swine fever virus. Proc Natl Acad Sci USA. 2023; 120: e2309506120.

[51] Silva AM, Lázaro-Ibáñez E, Gunnarsson A, et al. Quantification of protein cargo loading into engineered extracellular vesicles at single-vesicle and single-molecule resolution. J Extracellul Vesic. 2021; 10: e12130.

[52] Miranda KC, Bond DT, McKee M, et al. Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease. Kidney Int. 2010; 78: 191-199.

[53] Kowal J, Arras G, Colombo M, et al. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci USA. 2016; 113: E968-977.

[54] Isaac R, Reis FCG, Ying W, Olefsky JM. Exosomes as mediators of intercellular crosstalk in metabolism. Cell Metab. 2021; 33: 1744-1762.

[55] Corbeil D, Santos MF, Karbanová J, Kurth T, Rappa G, Lorico A. Uptake and fate of extracellular membrane vesicles: nucleoplasmic reticulum-associated late endosomes as a new gate to intercellular communication. Cells. 2020; 9.

[56] Lark DS, Stemmer K, Ying W, Crewe C. A brief guide to studying extracellular vesicle function in the context of metabolism. Nat Metab. 2024; 6: 1839-1841.

[57] Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracellul Vesic. 2018; 7: 1535750.

[58] Xiang H, Bao C, Chen Q, et al. Extracellular vesicles (EVs)' journey in recipient cells: from recognition to cargo release. J Zhejiang Univ Sci B. 2024; 25: 633-655.

[59] Ryan TA, Phillips EO, Collier CL, et al. Tollip coordinates Parkin-dependent trafficking of mitochondrial-derived vesicles. EMBO J. 2020; 39: e102539.

[60] Zhou X, Liu S, Lu Y, Wan M, Cheng J, Liu J. MitoEVs: a new player in multiple disease pathology and treatment. J Extracellul Vesic. 2023; 12: e12320.

[61] Crewe C, Funcke J, Li S, et al. Extracellular vesicle-based interorgan transport of mitochondria from energetically stressed adipocytes. Cell Metab. 2021; 33: 1853-1868e1811.

[62] Rosina M, Ceci V, Turchi R, et al. Ejection of damaged mitochondria and their removal by macrophages ensure efficient thermogenesis in brown adipose tissue. Cell Metab. 2022; 34: 533-548e512.

[63] Todkar K, Chikhi L, Desjardins V, El-Mortada F, Pépin G, Germain M. Selective packaging of mitochondrial proteins into extracellular vesicles prevents the release of mitochondrial DAMPs. Nat Commun. 2021; 12: 1971.

[64] Vikramdeo KS, Anand S, Sudan SK, et al. Profiling mitochondrial DNA mutations in tumors and circulating extracellular vesicles of triple-negative breast cancer patients for potential biomarker development. FASEB Bioadv. 2023; 5: 412-426.

[65] Liang W, Sagar S, Ravindran R, et al. Mitochondria are secreted in extracellular vesicles when lysosomal function is impaired. Nat Commun. 2023; 14: 5031.

[66] Soubannier V, Rippstein P, Kaufman BA, Shoubridge EA, McBride HM. Reconstitution of mitochondria derived vesicle formation demonstrates selective enrichment of oxidized cargo. PLoS One. 2012; 7: e52830.

[67] Han Q, Li W, Hu K, et al. Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer. Mol Cancer. 2022; 21: 207.

[68] Heyn J, Heuschkel MA, Goettsch C. Mitochondrial-derived vesicles-link to extracellular vesicles and implications in cardiovascular disease. Int J Mol Sci. 2023; 24.

[69] Kalkavan H, Chen MJ, Crawford JC, et al. Sublethal cytochrome c release generates drug-tolerant persister cells. Cell. 2022; 185: 3356-3374e3322.

[70] Schwager SC, Reinhart-King CA. Mechanobiology of microvesicle release, uptake, and microvesicle-mediated activation. Curr Top Membr. 2020; 86: 255-278.

[71] Sansone P, Savini C, Kurelac I, et al. Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer. Proc Natl Acad Sci USA. 2017; 114: E9066-E9075.

[72] Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science (New York, NY). 2020; 367.

[73] Tickner JA, Richard DJ, O'Byrne KJ. EV, microvesicles/microRNAs and stem cells in cancer. Adv Exp Med Biol. 2018; 1056: 123-135.

[74] Meldolesi J. Exosomes and ectosomes in intercellular communication. Curr Biol. 2018; 28: R435-R444.

[75] Zhang M, Schekman R. Cell biology. Unconventional secretion, unconventional solutions. Science (New York, NY). 2013; 340: 559-561.

[76] Cadete VJJ, Deschênes S, Cuillerier A, et al. Formation of mitochondrial-derived vesicles is an active and physiologically relevant mitochondrial quality control process in the cardiac system. J Physiol. 2016; 594: 5343-5362.

[77] Fan K, Li Y, Wang H, et al. Stress-induced metabolic disorder in peripheral CD4(+) T cells leads to anxiety-like behavior. Cell. 2019; 179: 864-879e819.

[78] Juhász G. A mitochondrial-derived vesicle HOPS to endolysosomes using Syntaxin-17. J Cell Biol. 2016; 214: 241-243.

[79] Hao T, Yu J, Wu Z, et al. Hypoxia-reprogramed megamitochondrion contacts and engulfs lysosome to mediate mitochondrial self-digestion. Nat Commun. 2023; 14: 4105.

[80] Hayashi Y, Takatori S, Warsame WY, Tomita T, Fujisawa T, Ichijo H. TOLLIP acts as a cargo adaptor to promote lysosomal degradation of aberrant ER membrane proteins. EMBO J. 2023; 42: e114272.

[81] Ponzetti M, Ucci A, Puri C, et al. Effects of osteoblast-derived extracellular vesicles on aggressiveness, redox status and mitochondrial bioenergetics of MNNG/HOS osteosarcoma cells. Front Oncol. 2022; 12: 983254.

[82] Wang W, Wang X, Fujioka H, et al. Parkinson's disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes. Nat Med. 2016; 22: 54-63.

[83] Abuaita BH, Schultz TL, O'Riordan MX. Mitochondria-derived vesicles deliver antimicrobial reactive oxygen species to control phagosome-localized Staphylococcus aureus. Cell Host Microbe. 2018; 24: 625-636e625.

[84] Herman S, Djaldetti R, Mollenhauer B, Offen D. CSF-derived extracellular vesicles from patients with Parkinson's disease induce symptoms and pathology. Brain. 2023; 146: 209-224.

[85] McLelland GL, Lee SA, McBride HM, Fon EA. Syntaxin-17 delivers PINK1/parkin-dependent mitochondrial vesicles to the endolysosomal system. J Cell Biol. 2016; 214: 275-291.

[86] Wurm CA, Neumann D, Lauterbach MA, et al. Nanoscale distribution of mitochondrial import receptor Tom20 is adjusted to cellular conditions and exhibits an inner-cellular gradient. Proc Natl Acad Sci USA. 2011; 108: 13546-13551.

[87] Gao S, Hu J. mitochondrial fusion: the machineries in and out. Trends Cell Biol. 2021; 31: 62-74.

[88] Picca A, Guerra F, Calvani R, et al. Mitochondrial dysfunction and aging: insights from the analysis of extracellular vesicles. Int J Mol Sci. 2019; 20.

[89] Kim P. Peroxisome biogenesis: a union between two organelles. Curr Biol. 2017; 27: R271-R274.

[90] Gaweda-Walerych K, Sitek EJ, Narożańska E, Buratti E. Parkin beyond Parkinson's disease - a functional meaning of Parkin downregulation in TDP-43 proteinopathies. Cells. 2021; 10.

[91] Ryan TA, Tumbarello DA. A central role for mitochondrial-derived vesicles in the innate immune response: implications for Parkinson's disease. Neural Regen Res. 2021; 16: 1779-1780.

[92] Zhou Q, Qi F, Zhou C, et al. VPS35 promotes gastric cancer progression through integrin/FAK/SRC signalling-mediated IL-6/STAT3 pathway activation in a YAP-dependent manner. Oncogene. 2024; 43: 106-122.

[93] Roberts RF, Bayne AN, Goiran T, et al. Proteomic profiling of mitochondrial-derived vesicles in brain reveals enrichment of respiratory complex sub-assemblies and small TIM chaperones. J Proteome Res. 2021; 20: 506-517.

[94] Mohanty A, Zunino R, Soubannier V, Dilipkumar S. A new functional role of mitochondria-anchored protein ligase in peroxisome morphology in mammalian cells. J Cell Biochem. 2021; 122: 1686-1700.

[95] Lu Y, He P, Zhang Y, Ren Y, Zhang L. The emerging roles of retromer and sorting nexins in the life cycle of viruses. Virol Sin. 2022; 37: 321-330.

[96] Wang L, Klionsky DJ, Shen HM. The emerging mechanisms and functions of microautophagy. Nat Rev Mol Cell Biol. 2023; 24: 186-203.

[97] Hernandez DG, Reed X, Singleton AB. Genetics in Parkinson disease: mendelian versus non-Mendelian inheritance. J Neurochem. 2016; 139(Suppl 1): 59-74.

[98] Jiao H, Jiang D, Hu X, et al. Mitocytosis, a migrasome-mediated mitochondrial quality-control process. Cell. 2021; 184: 2896-2910e2813.

[99] Samardzic K, Rodgers KJ. Oxidised protein metabolism: recent insights. Biological Chemistry. 2017; 398: 1165-1175.

[100] Hazan (Ben-Menachem) R, Lintzer D, Ziv T, et al. Mitochondrial-derived vesicles retain membrane potential and contain a functional ATP synthase. EMBO Rep. 2023; 24: e56114.

[101] Mishra E, Thakur MK. Vitamin B(12)-folic acid supplementation improves memory by altering mitochondrial dynamics, dendritic arborization, and neurodegeneration in old and amnesic male mice. J Nutr Biochem. 2024; 124: 109536.

[102] Zhu L, Zhang Q, Hua C, Ci X. Melatonin alleviates particulate matter-induced liver fibrosis by inhibiting ROS-mediated mitophagy and inflammation via Nrf2 activation. Ecotoxicol Environ Saf. 2023; 268: 115717.

[103] Goldberg MS, Fleming SM, Palacino JJ, et al. Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem. 2003; 278: 43628-43635.

[104] Kitada T, Tong Y, Gautier CA, Shen J. Absence of nigral degeneration in aged parkin/DJ-1/PINK1 triple knockout mice. J Neurochem. 2009; 111: 696-702.

[105] Mondal P, Towers C. Beyond mitophagy: mitochondrial-derived vesicles can get the job done!. Autophagy. 2022; 18: 449-451.

[106] Picca A, Faitg J, Auwerx J, Ferrucci L, D'Amico D. Mitophagy in human health, ageing and disease. Nat Metab. 2023; 5: 2047-2061.

[107] Mishra S, Deep G. Mitochondria-derived vesicles: potential nano-batteries to recharge the cellular powerhouse. Extracell Vesicles Circ Nucl Acids. 2024; 5: 271-275.

[108] Li H, Gong W, Sun W, Yao Y, Han Y. Role of VPS39, a key tethering protein for endolysosomal trafficking and mitochondria-lysosome crosstalk, in health and disease. J Cell Biochem. 2024; 125(11): e30396.

[109] Harper JW, Ordureau A, Heo JM. Building and decoding ubiquitin chains for mitophagy. Nat Rev Mol Cell Biol. 2018; 19: 93-108.

[110] Pickles S, Vigié P, Youle RJ. Mitophagy and quality control mechanisms in mitochondrial maintenance. Curr Biol. 2018; 28: R170-r185.

[111] Sheftel AD, Zhang AS, Brown C, Shirihai OS, Ponka P. Direct interorganellar transfer of iron from endosome to mitochondrion. Blood. 2007; 110: 125-132.

[112] Dimitrov L, Lam SK, Schekman R. The role of the endoplasmic reticulum in peroxisome biogenesis. Cold Spring Harb Perspect Biol. 2013; 5: a013243.

[113] Sugiura A, Mattie S, Prudent J, McBride HM. Newly born peroxisomes are a hybrid of mitochondrial and ER-derived pre-peroxisomes. Nature. 2017; 542: 251-254.

[114] Phinney DG, Di Giuseppe M, Njah J, et al. Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs. Nat Commun. 2015; 6: 8472.

[115] Liu D, Dong Z, Wang J, Tao Y, Sun X, Yao X. The existence and function of mitochondrial component in extracellular vesicles. Mitochondrion. 2020; 54: 122-127.

[116] Ferrucci L, Guerra F, Bucci C, Marzetti E, Picca A. Mitochondria break free: mitochondria-derived vesicles in aging and associated conditions. Age Res Rev. 2024; 102: 102549.

[117] Nicolás-Ávila JA, Lechuga-Vieco AV, Esteban-Martínez L, et al. A network of macrophages supports mitochondrial homeostasis in the heart. Cell. 2020; 183: 94-109e123.

[118] Yao W, Zhou J, Tang C, et al. Hydrogel microneedle patches loaded with stem cell mitochondria-enriched microvesicles boost the chronic wound healing. ACS nano. 2024; 18: 26733-26750.

[119] Hammood M, Craig AW, Leyton JV. Impact of endocytosis mechanisms for the receptors targeted by the currently approved antibody-drug conjugates (ADCs) - a necessity for future ADC research and development. Pharmaceuticals (Basel). 2021; 14.

[120] Miragoli M, Sanchez-Alonso J, Bhargava A, et al. Microtubule-dependent mitochondria alignment regulates calcium release in response to nanomechanical stimulus in heart myocytes. Cell Rep. 2016; 14: 140-151.

[121] Tu Y, Pal K, Austin J, Wang X. Filopodial adhesive force in discrete nodes revealed by integrin molecular tension imaging. Curr Biol. 2022; 32: 4386-4396e4383.

[122] Komori T, Kuwahara T. An update on the interplay between LRRK2, Rab GTPases and Parkinson's disease. Biomolecules. 2023; 13.

[123] Zhao YG, Codogno P, Zhang H. Machinery, regulation and pathophysiological implications of autophagosome maturation. Nat Rev Mol Cell Biol. 2021; 22: 733-750.

[124] Torralba D, Baixauli F, Villarroya-Beltri C, et al. Priming of dendritic cells by DNA-containing extracellular vesicles from activated T cells through antigen-driven contacts. Nat Commun. 2018; 9: 2658.

[125] Cheng AN, Cheng L, Kuo C, et al. Mitochondrial Lon-induced mtDNA leakage contributes to PD-L1-mediated immunoescape via STING-IFN signaling and extracellular vesicles. J Immunother Cancer. 2020; 8.

[126] Decout A, Katz JD, Venkatraman S, Ablasser A. The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nat Rev Immunol. 2021; 21: 548-569.

[127] Marchi S, Guilbaud E, Tait SWG, Yamazaki T, Galluzzi L. Mitochondrial control of inflammation. Nat Rev Immunol. 2023; 23: 159-173.

[128] Chen L, Dong J, Liao S, et al. Loss of Sam50 in hepatocytes induces cardiolipin-dependent mitochondrial membrane remodeling to trigger mtDNA release and liver injury. Hepatology. 2022; 76: 1389-1408.

[129] Ivashkiv LB, Donlin LT. Regulation of type I interferon responses. Nat Rev Immunol. 2014; 14: 36-49.

[130] Sahoo BR. Structure of fish Toll-like receptors (TLR) and NOD-like receptors (NLR). Int J Biol Macromol. 2020; 161: 1602-1617.

[131] Fu R, Zhao L, Guo Y, et al. AIM2 inflammasome: a potential therapeutic target in ischemic stroke. Clin Immunol. 2024; 259: 109881.

[132] Lee S, Karki R, Wang Y, Nguyen LN, Kalathur RC, Kanneganti T. AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence. Nature. 2021; 597: 415-419.

[133] Lu A, Wu S, Niu J, et al. Aim2 couples With Ube2i for sumoylation-mediated repression of interferon signatures in systemic lupus erythematosus. Arthritis Rheumatol. 2021; 73: 1467-1477.

[134] Zhang P, Liu Y, Hu L, et al. NLRC4 inflammasome-dependent cell death occurs by a complementary series of three death pathways and determines lethality in mice. Sci Adv. 2021; 7: eabi9471.

[135] Kong F, You H, Zheng K, Tang R, Zheng C. The crosstalk between pattern-recognition receptor signaling and calcium signaling. Int J Biol Macromol. 2021; 192: 745-756.

[136] Li J, Xiao J, Gao M, et al. IRF/Type I IFN signaling serves as a valuable therapeutic target in the pathogenesis of inflammatory bowel disease. Int Immunopharmacol. 2021; 92: 107350.

[137] Zhang L, Wei X, Wang Z, et al. NF-kappaB activation enhances STING signaling by altering microtubule-mediated STING trafficking. Cell Rep. 2023; 42: 112185.

[138] Monzel AS, Enríquez JA, Picard M. Multifaceted mitochondria: moving mitochondrial science beyond function and dysfunction. Nat Metab. 2023; 5: 546-562.

[139] Bajwa E, Pointer CB, Klegeris A. The role of mitochondrial damage-associated molecular patterns in chronic neuroinflammation. Mediators Inflamm. 2019; 2019: 4050796.

[140] Schindler SM, Frank MG, Annis JL, Maier SF, Klegeris A. Pattern recognition receptors mediate pro-inflammatory effects of extracellular mitochondrial transcription factor A (TFAM). Mol Cell Neurosci. 2018; 89: 71-79.

[141] Wenzel TJ, Bajwa E, Klegeris A. Cytochrome c can be released into extracellular space and modulate functions of human astrocytes in a toll-like receptor 4-dependent manner. Biochim Biophys Acta Gen Subj. 2019; 1863: 129400.

[142] Poillet-Perez L, White E. MDVs to the rescue: how autophagy-deficient cancer cells adapt to defective mitophagy. Dev Cell. 2021; 56: 2010-2012.

[143] Tang M, Tu Y, Gong Y, et al. beta-hydroxybutyrate facilitates mitochondrial-derived vesicle biogenesis and improves mitochondrial functions. Molecular Cell. 2025; 85: 1395-1410e1395.

[144] Bao D, Zhao J, Zhou X, et al. Mitochondrial fission-induced mtDNA stress promotes tumor-associated macrophage infiltration and HCC progression. Oncogene. 2019; 38: 5007-5020.

[145] Takenaga K, Koshikawa N, Nagase H. Intercellular transfer of mitochondrial DNA carrying metastasis-enhancing pathogenic mutations from high- to low-metastatic tumor cells and stromal cells via extracellular vesicles. BMC Mol Cell Biol. 2021; 22: 52.

[146] Zhao F, Sun L, Yang N, et al. Increased release of microvesicles containing mitochondria is associated with the myeloid differentiation of AML-M5 leukaemia cells. Exp Cell Res. 2020; 395: 112213.

[147] Abad E, Lyakhovich A. Movement of Mitochondria with mutant DNA through extracellular vesicles helps cancer cells acquire chemoresistance. ChemMedChem. 2022; 17: e202100642.

[148] Salaud C, Alvarez-Arenas A, Geraldo F, et al. Mitochondria transfer from tumor-activated stromal cells (TASC) to primary glioblastoma cells. Biochem Biophys Res Commun. 2020; 533: 139-147.

[149] Hall AJ, Robertson AG, Hill LR, Rendina LM. Synthesis and tumour cell uptake studies of gadolinium(III)-phosphonium complexes. Sci Rep. 2021; 11: 598.

[150] Jiang H, Guo Y, Wei C, Hu P, Shi J. Nanocatalytic innate immunity activation by mitochondrial DNA oxidative damage for tumor-specific therapy. Adv Mater. 2021; 33: e2008065.

[151] Yang G, Pan Z, Zhang D, Cao Q, Ji L, Mao Z. Precisely assembled nanoparticles against cisplatin resistance via cancer-specific targeting of mitochondria and imaging-guided chemo-photothermal therapy. ACS Appl Mater Interfaces. 2020; 12: 43444-43455.

[152] Dickhout A, Koenen RR. Extracellular vesicles as biomarkers in cardiovascular disease; chances and risks. Front Cardiovasc Med. 2018; 5: 113.

[153] Vasam G, Nadeau R, Cadete VJJ, Lavallée-Adam M, Menzies KJ, Burelle Y. Proteomics characterization of mitochondrial-derived vesicles under oxidative stress. FASEB J. 2021; 35: e21278.

[154] Zhao Q, Liu Z, Song P, Yuan Z, Zou MH. Mitochondria-derived vesicle packaging as a novel therapeutic mechanism in pulmonary hypertension. Am J Respir Cell Mol Biol. 2024; 70: 39-49.

[155] Chaiyarit S, Thongboonkerd V. Mitochondria-derived vesicles and their potential roles in kidney stone disease. J Transl Med. 2023; 21: 294.

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.